Investigating the Role of a Novel Kappa Opioid Receptor Agonist in Functional Recovery in the Augmented Cuprizone Model of Demyelination and Its Side Effects
JavaScript is disabled for your browser. Some features of this site may not work without it.
Investigating the Role of a Novel Kappa Opioid Receptor Agonist in Functional Recovery in the Augmented Cuprizone Model of Demyelination and Its Side Effects